The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application

Human mesenchymal stem cells derived from Wharton’s jelly (WJ-MSCs) were used for the treatment of the ischemic-compression model of spinal cord injury in rats. To assess the effectivity of the treatment, different dosages (0.5 or 1.5 million cells) and repeated applications were compared. Cells or...

Descripción completa

Detalles Bibliográficos
Autores principales: Krupa, Petr, Vackova, Irena, Ruzicka, Jiri, Zaviskova, Kristyna, Dubisova, Jana, Koci, Zuzana, Turnovcova, Karolina, Machova Urdzikova, Lucia, Kubinova, Sarka, Rehak, Svatopluk, Jendelova, Pavla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983761/
https://www.ncbi.nlm.nih.gov/pubmed/29772841
http://dx.doi.org/10.3390/ijms19051503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983761/
https://www.ncbi.nlm.nih.gov/pubmed/29772841
http://dx.doi.org/10.3390/ijms19051503

Ejemplares similares